Clinical Trial Update: A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the safety and effectiveness of Gammaplex in youths with primary immunodeficiency disorders, including Common Variable Immunodeficiency…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Variable Immunodeficiency
• Hyper-igm Syndrome
• Immunodeficiency
• Wiskott-aldrich Syndrome
• X-linked Agammaglobulinemia

Drugs mentioned

• GAMMAPLEX (intravenous immunoglobulin (IVIG))

Snippet

Sponsor: Bio Products Laboratory | Conditions: Primary Immune Deficiency Disorders, Common Variable Immunodeficiency | Phase 4 | Status: COMPLETED | Results posted: 2014-12-23